文献速递胸部外周血管神经CTMRUS

住院新型冠状病毒病(COVID-19)患者凝血病影像表现的多系统评估

Multisystem Assessment of the Imaging Manifestations of Coagulopathy in Hospitalized Patients With Coronavirus Disease (COVID-19).
PubMed 文献 · AJR Am J Roentgenol · 2021-02-03

本研究回顾性分析3周内连续入院的308例COVID-19成人患者,其中142例(46%)接受332次横断面影像检查,37例(26%)影像阳性提示凝血病,最常见为肺动脉栓塞(n=21)、四肢静脉血栓(n=13)、肠与肾梗死(各n=4)及脑血栓或梗死(n=2),8例(22%)为多部位受累;多变量分析显示插管(p<.001)和凝血酶原时间延长(p=.04)与接受影像检查显著相关,但无患者变量与影像阳性显著相关。

要点

  • 住院COVID-19患者中凝血病影像表现常见,阳性者中22%为多部位受累。
  • 最常见表现为对比增强CT/CTA上的肺动脉栓塞(n=21)和多普勒超声上的四肢静脉血栓(n=13)。
  • 临床变量难以预测影像阳性,影像在检出COVID-19相关凝血病中起互补作用。

核心结论

  • 住院COVID-19患者影像常显示凝血病表现,超过五分之一的阳性患者为多部位受累。
  • 临床变量难以预测哪些患者影像阳性,提示影像在检出COVID-19相关凝血病中起互补作用。

研究设计与样本

  • 回顾性研究,连续纳入3周期间本院住院的308例COVID-19成人患者。
  • 收集人口学、血液学指标、横断面影像检查及临床结局(死亡和插管)数据。
  • 影像由研究者审阅凝血病表现,并采用多变量logistic回归分析人口学、血液学标志物及结局与接受影像检查和影像凝血病表现的相关性。

关键影像表现/征象

  • 对比增强CT或CTA示肺动脉栓塞(n=21),为最常见的凝血病影像表现。
  • 多普勒超声示上肢或下肢静脉血栓(n=13),血栓可累及浅静脉、深静脉或两者。
  • 对比增强CT示肠梗死(n=4)和肾梗死(n=4)。
  • 对比增强CTA或MRI联合MRA示脑内血栓或实质梗死(n=2)。
  • 影像阳性患者中8例(22%)存在多部位受累;上肢静脉检查阳性5例中4例血栓为多灶性,下肢静脉检查阳性8例中3例血栓为多灶性。

临床应用与阅片要点

  • 作者在临床影响中指出,对疑似全身性凝血病的COVID-19患者,在无影像禁忌时,肺动脉CTA、四肢多普勒超声、对比增强腹部CT及对比增强脑MRI和MRA可能均适用。
  • 多变量分析中插管(p<.001)和凝血酶原时间延长(p=.04)与接受影像检查显著相关。
  • 无患者变量与影像阳性凝血病表现显著相关(p>.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Coronavirus disease (COVID-19) is known to be associated with a distinct form of coagulopathy. OBJECTIVE. The purpose of this study was to describe the imaging manifestations of COVID-19-associated coagulopathy across anatomic sites and modalities in hospitalized patients and to identify clinical variables associated with positive imaging findings. METHODS. We conducted a retrospective review of consecutive adult patients with COVID-19 admitted to our hospital over a 3-week period. Data on patient demographics, hematologic values, cross-sectional imaging examinations, and clinical outcomes (death and intubation) were collected. Imaging was reviewed for manifestations of coagulopathy. Multivariable logistic regression analyses were performed to assess associations of patient demographics, hematologic markers, and outcomes with the need for imaging and imaging manifestations of coagulopathy. RESULTS. Of 308 hospitalized patients with COVID-19, 142 (46%) underwent 332 cross-sectional imaging examinations. Of these, 37 (26%) had imaging results positive for coagulopathy. The most common imaging manifestations of coagulopathy were pulmonary embolus (n = 21) on contrast-enhanced CT or CTA, thrombus in the upper- or lower-extremity veins (n = 13) on Doppler ultrasound, end-organ infarction in the bowel (n = 4) and kidney (n = 4) on contrast-enhanced CT, and thrombus or parenchymal infarction in the brain (n = 2) on contrast-enhanced CTA or MRI with MRA. Among patients with imaging results positive for coagulopathy, eight (22%) had multisite involvement. Thrombi were multifocal in four of five patients with positive upper-extremity and three of eight patients with positive lower-extremity examination results and involved superficial veins, deep veins, or both. In multivariable analysis, intubation (p < .001) and prolonged prothrombin time (p = .04) were significantly associated with undergoing imaging. No patient variable was significantly associated with imaging results positive for coagulopathy (p > .05). CONCLUSION. Imaging commonly shows manifestations of coagulopathy in hospitalized patients with COVID-19. Over one-fifth of patients with such manifestations show multisite involvement. Clinical variables poorly predict which patients have positive imaging results, indicating a complementary role of imaging in detecting COVID-19-associated coagulopathy. CLINICAL IMPACT. In patients with COVID-19 with suspected systemic coagulopathy, pulmonary CTA, extremity Doppler ultrasound, contrast-enhanced abdominal CT, and contrast-enhanced brain MRI and MRA may all be appropriate in the absence of imaging contraindications.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. O'Shea A, Parakh A, Hedgire S, et al. Multisystem Assessment of the Imaging Manifestations of Coagulopathy in Hospitalized Patients With Coronavirus Disease (COVID-19). AJR Am J Roentgenol. 2021. PMID: 32755217. doi:10.2214/AJR.20.24132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。